{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:48:08Z","timestamp":1761871688148,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clml.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T17:55:57Z","timestamp":1623606957000},"page":"e768-e774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single Fraction Radiation for Myeloid Sarcoma Is as Effective as Multi-Fraction Regimens for Tumor Regression and Control"],"prefix":"10.1016","volume":"21","author":[{"given":"Eric G.","family":"Nesbit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat B.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clml.2021.06.001_bib0001","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.clml.2021.06.001_bib0002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0002-9343(91)90559-G","article-title":"Granulocytic sarcoma in myelodysplastic syndromes: clinical marker of disease acceleration","volume":"90","author":"List","year":"1991","journal-title":"Am J Med"},{"issue":"5\u20136","key":"10.1016\/j.clml.2021.06.001_bib0003","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s002770050350","article-title":"Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation","volume":"75","author":"Szomor","year":"1997","journal-title":"Ann Hematol"},{"issue":"14","key":"10.1016\/j.clml.2021.06.001_bib0004","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2021.06.001_bib0005","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.ijrobp.2011.02.057","article-title":"Radiation therapy for chloroma (granulocytic sarcoma)","volume":"82","author":"Bakst","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clml.2021.06.001_bib0006","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijrobp.2018.05.045","article-title":"Use of radiation in extramedullary leukemia\/chloroma: guidelines from the International Lymphoma Radiation Oncology Group","volume":"102","author":"Bakst","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.clml.2021.06.001_bib0007","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0360-3016(83)90176-1","article-title":"Extramedullary lesions in non-lymphocytic leukemia: results of radiation therapy","volume":"9","author":"Chak","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clml.2021.06.001_bib0008","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1748-717X-8-245","article-title":"Clinicopathologic features and responses to radiotherapy of myeloid sarcoma","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.clml.2021.06.001_bib0009","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1754-9485.12172","article-title":"Treatment outcomes for patients with chloroma receiving radiation therapy","volume":"58","author":"Hall","year":"2014","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"2","key":"10.1016\/j.clml.2021.06.001_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00066-017-1236-4","article-title":"Radiotherapy for extramedullary leukaemic manifestation (chloroma)","volume":"194","author":"Oertel","year":"2018","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.clml.2021.06.001_bib0011","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2012.05.034","article-title":"Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma","volume":"85","author":"Thomas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clml.2021.06.001_bib0012","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clml.2021.06.001_bib0013","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/j.clml.2019.02.010","article-title":"Utilization patterns of single fraction radiation therapy for multiple myeloma","volume":"19","author":"Resende Salgado","year":"2019","journal-title":"Clin lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.clml.2021.06.001_bib0014","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clml.2014.07.003","article-title":"Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients","volume":"14","author":"Haque","year":"2014","journal-title":"Clin lymphoma Myeloma Leuk"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:37:32Z","timestamp":1761871052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2152265021002068"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.06.001","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single Fraction Radiation for Myeloid Sarcoma Is as Effective as Multi-Fraction Regimens for Tumor Regression and Control","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}